Cargando…

A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma

The 5-year survival of hepatocellular carcinoma (HCC) is difficult due to the high recurrence rate and metastasis. Tumor infiltrating immune cells (TICs) and immune-related genes (IRGs) bring hope to improve survival and treatment of HCC patients. However, there are problems in predicting immune sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Huan, Hu, Huan, Tian, Feifei, Liang, Huaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969702/ https://www.ncbi.nlm.nih.gov/pubmed/33656546 http://dx.doi.org/10.1042/BSR20204219

Ejemplares similares

Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma
por: Yang, Lei, et al.
Publicado: (2021)

Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma
por: Xu, Wenfang, et al.
Publicado: (2021)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2020)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
por: Li, Jiangfen, et al.
Publicado: (2019)

In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis
por: Ghanekar, Yashoda, et al.
Publicado: (2019)

A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma
por: Miao, Ti-wei, et al.
Publicado: (2022)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2020)

Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
por: Wang, Sheng, et al.
Publicado: (2023)

MMP12 serves as an immune cell–related marker of disease status and prognosis in lung squamous cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

A transcription factor signature predicts the survival of patients with adrenocortical carcinoma
por: Zhao, Jianyu, et al.
Publicado: (2021)

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
por: Yang, Hong, et al.
Publicado: (2017)

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

An angiogenesis‐related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma
por: Lei, Dengliang, et al.
Publicado: (2021)

Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma
por: Gao, Xinliang, et al.
Publicado: (2021)

Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2020)

A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma
por: Zhang, Zewei, et al.
Publicado: (2023)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
por: Wang, Zhonghao, et al.
Publicado: (2017)

Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune‐related lncRNA
por: Shen, Shuang, et al.
Publicado: (2021)

A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
por: Yang, Jingze, et al.
Publicado: (2023)

A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2019)

Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma
por: Wan, Sizhe, et al.
Publicado: (2020)

Gene signatures with predictive and prognostic survival values in human osteosarcoma
por: Qiu, Zhongpeng, et al.
Publicado: (2021)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma
por: Liang, Jialu, et al.
Publicado: (2022)

Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report
por: Lü, Ying, et al.
Publicado: (2020)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Tumor microenvironment related novel signature predict lung adenocarcinoma survival
por: Chen, Juan, et al.
Publicado: (2021)

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
por: Ji, Baowei, et al.
Publicado: (2020)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pdv4u0ov25nnvhotu8l4uao56s